Renal Carcinoma (Clear and Non-clear Cell)

1

Review clinical trials related to Renal Carcinoma (Clear and Non-clear Cell). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

The primary purpose of this study is to determine the safety, tolerability, and maximum tolerated dose (MTD) of EXS74539 (REC-4539) in participants with select solid tumors.

Participants needed: 40
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.Updated: Jun 10, 2026Locations: 3
Eligibility criteria

Eastern Cooperative Oncology Group (ECOG) performance status of 0-1. [+12]

Any medical or psychiatric condition that, in the opinion of the Investigator, c... [+4]